Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells
نویسندگان
چکیده
Antigen presentation via major histocompatibility complex (MHC) class I and II receptors plays a fundamental role in T cell-mediated adaptive immunity. A dysregulation of this fine-tuned recognition might result the development autoimmune diseases such as inflammatory bowel that are characterized by chronic relapsing inflammation intestinal tract damaged epithelial barrier. While MHCII usually expressed professional antigen presenting cells (APC) only, there is increasing evidence non-immune (IEC) express upon stimulation with IFN-γ thus act non-professional APC. However, little known about other factors regulating MHC expression. Here, we identify IL-27 an inducer different MHCI receptor subtypes invariant chain (CD74/li) IEC STAT1/IRF1/CIITA axis. CIITA, MHCII, CD74 expression was significantly increased from Crohn’s disease (CD) patients active compared to controls or CD remission. phagocytosed digested external antigens apoptotic cells. strongly stimulated processing immunoproteasome IRF1-dependent manner. In co-culture experiments, antigen-primed enhanced lymphocyte proliferation IL-2 secretion, dependent on direct cell-cell contact. pretreatment CD4 + cell reduced levels lymphocytes coculture. summary, identified novel regulator receptors, underscoring importance
منابع مشابه
Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
Antigen presentation by major histocompatibility complex (MHC) proteins is essential for adaptive immunity. Prior to presentation, peptides need to be generated from proteins that are either produced by the cell's own translational machinery or that are funneled into the endo-lysosomal vesicular system. The prolonged interaction between a T cell receptor and specific pMHC complexes, after an ex...
متن کاملFrequency of Major Histocompatibility Antigens Class I in Mazandaran Province
Background and purpose: Major histocompatibility antigens are the most polymorphic components of the immune system. The purpose of this study was to determine the frequency of human leukocyte antigens (HLA) in a population in Mazandaran province, Iran. Materials and methods: In a cross sectional study, peripheral blood samples were obtained from 550 people in Immunogenetics Research Center af...
متن کاملDeficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's disease tumor cells.
Hodgkin's disease is a common malignancy of the lymphoid system. Although the scarce Hodgkin and Reed-Sternberg (HRS) tumor cells in involved tissue synthesize major histocompatibility complex (MHC) class II and costimulatory molecules such as CD40 or CD86, it is unclear whether these tumor cells are operational antigen-presenting cells (APC). We developed an immunofluorescence-based assay to d...
متن کاملCytokines Regulate Proteolysis in Major Histocompatibility Complex Class II–Dependent Antigen Presentation by Dendritic Cells
Endo/lysosomal proteases control two key events in antigen (Ag) presentation: the degradation of protein Ag and the generation of peptide-receptive major histocompatibility complex (MHC) class II molecules. Here we show that the proinflammatory cytokines tumor necrosis factor alpha and interleukin (IL)-1beta rapidly increase the activity of cathepsin (cat) S and catB in human dendritic cells (D...
متن کاملExpression Regulation of Major Histocompatibility Complex Class I and Class II Encoding Genes
Major histocompatibility complex (MHC)-I and MHC-II molecules play an essential role in the immune response to pathogens by virtue of their ability to present peptides to CD8⁺ and CD4⁺ T cells, respectively. Given this critical role, MHC-I and MHC-II genes are regulated in a tight fashion at the transcriptional level by a variety of transcription factors that interact with conserved cis-acting ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Immunology
سال: 2023
ISSN: ['1664-3224']
DOI: https://doi.org/10.3389/fimmu.2023.1226809